Science & Enterprise subscription

Follow us on Twitter

  • A company discovering therapeutic antibodies identified antibodies considered particularly effective in neutralizin… https://t.co/cHHeuebOv4
    about 13 hours ago
  • New post on Science and Enterprise: Biotech IDs Potent Covid-19 Antibodies https://t.co/kDv6E821aA #Science #Business
    about 13 hours ago
  • Researchers discovered a polymer compound added to insulin that in tests with pigs cuts insulin's acting time in ha… https://t.co/iHe65RlMnW
    about 18 hours ago
  • New post on Science and Enterprise: Polymer Boosts Insulin Speed, Stability https://t.co/PeSuWepIAH #Science #Business
    about 18 hours ago
  • A new venture investment company is funding start-ups at their earliest stages, with a goal of increasing support f… https://t.co/mM44gsVcT9
    about 2 days ago

Please share Science & Enterprise

Editorial – No More Business as Usual

Protest sign

As much as Science & Enterprise tries to stick to its reporting of science news for business people, and enterprise for scientists, sometimes events of the day overtake our usual news topics. . . . → Read More: Editorial – No More Business as Usual

Commentary – Biotech, Trump’s Latest Casino

SARS-Cov-2 virus

If you thought the Trump administration couldn’t bungle any worse its response to the coronavirus pandemic, think again. . . . → Read More: Commentary – Biotech, Trump’s Latest Casino

Int’l Group Funding Coronavirus Vaccines

Health screening Shanghai

An international health coalition is funding development of vaccines against the new coronavirus outbreak spreading quickly through China and to other countries. . . . → Read More: Int’l Group Funding Coronavirus Vaccines

Commentary – New Models Needed for Antibiotic Resistance

MRSA bacteria

Many parts of a new model for fighting antibiotic resistance are in development, and the pieces still need to be assembled, but the outline of a precision-medicine rather than mass-produced drug model is beginning to emerge. . . . → Read More: Commentary – New Models Needed for Antibiotic Resistance

FDA Chief Calls Teen Vaping an “Epidemic”

Scott Gottlieb at Brookings Institution

The commissioner of the Food and Drug Administration warned that the sharp rise in teen electronic cigarette use is an epidemic threatening the public health. . . . → Read More: FDA Chief Calls Teen Vaping an “Epidemic”

Insulin Delivered by Capsule, That’s the Good News

Diabetes word cloud

Before we start celebrating the end of injections, we need to deal with a more basic problem facing people with diabetes, namely the rapidly rising cost of insulin. . . . → Read More: Insulin Delivered by Capsule, That’s the Good News

Book Review – The Fifth Risk

The Fifth Risk cover

Michael Lewis describes in a gripping narrative some of those critical life-protecting functions the federal government performs in his new book The Fifth Risk. . . . → Read More: Book Review – The Fifth Risk

Personalized Breast Cancer Trial Advances 7 Drugs

Laura Esserman

A clinical trial with a design that allows for changes in its processes to meet the needs of individual patients says its results helped advance 7 new drugs for breast cancer into review by FDA. . . . → Read More: Personalized Breast Cancer Trial Advances 7 Drugs

You Call That a Drug Pricing Policy?

Pills on money

Although he called it, “the most sweeping action in history to lower the price of prescription drugs for the American people,” the plan was anything but that. . . . → Read More: You Call That a Drug Pricing Policy?

Drug Price Report Calls for Govt Negotiation, More Generics

A panel convened by the National Academies calls for the federal government to use its buying power to negotiate better drug prices for consumers. . . . → Read More: Drug Price Report Calls for Govt Negotiation, More Generics